Loading
Latest filing published 21 Jan 2009 for REGEN BIOLOGICS INC, €45k.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
William R. Timken appears in our data through filings on Regen Biologics Inc shares, published by SEC (Form 4). Between 30 November 2006 and 16 January 2009, the trades on record add up to 4 filings.
On the market, this insider has only ever bought: 3 purchases, €121k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. 2009 to date brings 1 purchase and no sales.
A typical purchase (the median) is worth €45k.
On 21 January 2009 came the latest disclosure, an open-market purchase for €45k in Regen Biologics Inc. The median gap between a trade and its publication by SEC (Form 4) is 5 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations